Related Experiment Video
Updated: May 5, 2026

Simultaneous Measurements of Intracellular Calcium and Membrane Potential in Freshly Isolated and Intact Mouse Cerebral Endothelium
Published on: January 20, 2019
TRPV4 in Cerebral Small Vessel Disease: A key interacting partner.
Sara M P Lambrichts1, Robert J van Oostenbrugge2, Sébastien Foulquier3
1Dept of Pharmacology and Toxicology, Maastricht University, the Netherlands; Dept of Neurology, Maastricht University Medical Center, the Netherlands; MHeNS, Mental Health and Neuroscience Research institute, Maastricht University, the Netherlands.
Transient Receptor Potential Vanilloid 4 (TRPV4) channels are implicated in cerebral small vessel disease (cSVD), a cause of vascular dementia. Understanding TRPV4’s role in the neurovascular unit is key to developing new treatments for cSVD.
Area of Science:
- Neuroscience
- Vascular Biology
- Mechanobiology
Background:
- Cerebral small vessel disease (cSVD) is a primary cause of vascular cognitive impairment and dementia.
- cSVD pathogenesis involves neurovascular unit dysfunction, including blood-brain barrier (BBB) impairment, reduced cerebrovascular reactivity, and hypoperfusion.
- Mechanosensitive ion channels in the neurovascular unit are critical for these processes.
Purpose of the Study:
- To review the multifaceted roles of Transient Receptor Potential Vanilloid 4 (TRPV4) channels within the neurovascular unit.
- To explore TRPV4's interactions with molecular partners.
- To discuss the potential contribution of TRPV4 to the pathophysiology of cSVD.
Main Methods:
- Literature review focusing on mechanobiology of cerebral microvessels.
- Analysis of recent evidence on TRPV4's physiological and pathological roles.
- Synthesis of findings related to TRPV4 and cSVD mechanisms.
Main Results:
- TRPV4 channels regulate key physiological functions: vascular tone, angiogenesis, BBB integrity, and neuroinflammation.
- TRPV4 is implicated in pathological processes including cerebrovascular remodeling, impaired reactivity, and BBB dysfunction.
- TRPV4 channels are expressed in cells of the neurovascular unit, suggesting a direct role in cSVD.
Conclusions:
- TRPV4 plays a significant role in the normal functioning of the neurovascular unit.
- Dysregulation of TRPV4 contributes to pathological changes observed in cSVD.
- Targeting TRPV4 may offer a therapeutic strategy for managing cSVD and related cognitive decline.
Related Concept Videos
The Blood-brain Barrier
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Vascular Spasm
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke ll: Pathophysiology
Cerebral Edema ll: Pathophysiology

